Inhibition of F-box protein p45SKP2 expression and stabilization of cyclin-dependent kinase inhibitor p27KIP1 in vitamin D analog-treated cancer cells

Endocrinology

Volumn 144, Issue 3, 2003, Pages 749-753

  Lin, Roberto ^a   Wang, Tian Tian ^a   Miller Jr , Wilson H ^b,c   White, John H ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Montreal Ctr Exp Therapeut Cancer   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CALCITRIOL; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PROTEIN; PROTEIN P27; PROTEIN P45; SEOCALCITOL; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; ENZYME SUBUNIT; GENETIC TRANSCRIPTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; CALCITRIOL; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DRUG STABILITY; ENZYME INHIBITORS; G0 PHASE; G1 PHASE; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOSORBENT TECHNIQUES; MICE; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; S-PHASE KINASE-ASSOCIATED PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0037372015     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-0026     Document Type: Article

References (19)

1. Jones G, Strugnell SA, DeLuca H 1998 Current understanding of the molecular actions of vitamin D. Physiol Rev 78:1193-1231
2. Prudencio J, Akutsu N, Wong T, Bastien Y, Lin R, Black MJ, Alaoui-Jamali M, White JH 2001 Action of low calcemic 1α, 25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma. J Natl Cancer Inst 93:745-753
3. Akutsu N, Lin R, Bastien Y, Bestawros A, Enepekides DJ, Black MJ, White JH 2001 Regulation of gene expression by 1α, 25-dihydroxyvitamin D3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma cells. Mol Endocrinol 15:1127-1139
4. 3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol 16:1243-1256
5. Benner SE, Pajak TF, Lippman SM, Earley C, Hong WK 1994 Prevention of second primary humors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J Natl Cancer Inst 86:140-141
6. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP 1996 Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142-153
7. Munker R, Kobayashi T, Elstner E, Norman AW, Uskokovic M, Zhang W, Andreeff M, Koeffler HP 1996 A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. Blood 88:2201-2209
8. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS 1999 1,25-Dihydroxycholecalciferol (1, 25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res 59:2644-2649
9. Muto A, Kizaki M, Yamato K, Kawai Y, Kamata-Matsushita M, Ueno H, Ohguchi M, Nishihara T, Koeffler HP, Ikeda Y 1999 1, 25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1). Blood 93:2225-2233
10. Spruck C, Strolmeier H, Watson M, Smith APL, Ryan A, Krek W, Reed SI 2001 A CDK-independent function of mammalian Cks1: targeting of SCF-(Skp2) to the CDK inhibitor p27Kip1. Mol Cell 7:639-650
11. Ganoth D, Bernstein G, Ko TK, Larsen B, Tyers M, Pagano M, Hershko A 2001 The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol 3:321-324
12. Harper JW 2001 Protein destruction: adapting roles for Cks proteins. Curr Biol 11:R431-R435
13. Mongay L, Plaza S, Vigorito E, Serra-Pagès C, Vives J 2001 Association of the cell cycle regulatory, proteins p45(SKP2) and CksHs1. Functional effect on CDK2 complex formation and kinase activity. J Biol Chem 276:25030-25036
14. Malumbres M, Barbacid M 2001 To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1:222-231
15. Inoue T, Kamiyama J, Sakai T 1999 Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements. J Biol Chem 274:32309-2317
16. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ 1998 The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396:177-180
17. Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I, Takata T 2001 High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res 61:7044 -7047
18. Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, Krek W 2001 Skp2 is oncogenic and overexpressed in human cancers. Proc Nat Acad Sci USA 98:5043-5048
19. Latres E, Chiarle R, Schulman B, Pavlevich N, Pellicer A, Inghirami G, Pagano M 2001 Role of the F-box protein Skp2 in lymphomagenesis. Proc Natl Acad Sci USA 98:2515-2520